Viewbix Inc. has signed a definitive agreement to acquire up to 100%, but not less than 85%, of Quantum X Labs Ltd., an Israeli multi-disciplinary quantum technology company. The acquisition, which encompasses Quantum X Labs’ expanding patent portfolio—including advancements in quantum error correction—follows recent demonstrations of the company’s technology at major international conferences. The deal is expected to close within 90 days of the mid-December 2025 agreement, pending final due diligence, regulatory approvals, and other customary closing conditions. Viewbix highlights the timing of the acquisition as strategic, given the rapid growth expected in fields such as personalized medicine and quantum-based security, and points to Quantum X Labs’ combination of patented innovations and elite talent as key assets for future commercialization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viewbix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9618990-en) on January 02, 2026, and is solely responsible for the information contained therein.